Back to search
Moderate Upper Facial Lines
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Moderate Upper Facial Lines trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Moderate Upper Facial Lines trials you may qualify forThe purpose of this study is to assess the safety and efficacy profile of increasing doses of IPN10200 in comparison to placebo, with the aim to discover the do…
The purpose of this study is to investigate the safety and efficacy of NT 201 (active ingredient: Botulinum (neuro)toxin type A, free from complexing proteins)…
The purpose of this study is to investigate the safety and efficacy of NT 201 (active ingredient: Botulinum (neuro)toxin type A, free from complexing proteins)…
The purpose of the protocol, is to assess the safety and efficacy profile of IPN59011 compared to a placebo. IPN59011 is expected to work longer than product al…